Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Growth Hormone In Heart Failure Trial
NCT00182169Phase 2Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Jul 1997
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised trial in heart failure (HF) comparing Human recombinant growth hormone with Placebo (2 arms). Primary endpoint: 6-minute walk test distance at 9 months. Started Jul 1997; status: completed.
02
Drugs
somatropin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00182169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182169.